Other News To Note
Monday, March 28, 2011
Boehringer Ingelheim GmbH, of Ingelheim, Germany, acquired a biopharmaceutical development and manufacturing facility in Fremont, Calif., from Amgen Inc., of Thousand Oaks, Calif. The facility contains more than 200,000 square feet of laboratory space and employs more than 300 people.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.